Evidence map›Paper›PMID 42244761›Full record

ArticlebioRxiv : the preprint server for biology2026

Minimal Computational Framework for Systematic Identification of Antimicrobial Targets.

Sergio A Hassan

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sergio A HassanBioinformatics and Computational Biosciences Branch, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, U.S. DHHS, Bethesda, MD 20892.ORCID 0000-0003-3319-078X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systematic identification of antimicrobial targets remains a major challenge, as discovery still relies largely on empirical, resource-intensive approaches with limited efficiency. We present a method for identifying antimicrobial targets based on protein dynamics, enabling rational polypharmacology. The approach spans multiple biological scales, from taxa (genus and species) to biological networks, including network hubs and edges, their constituent proteins, protein binding sites, and their conformational states. It is grounded in the premise that coordinated intervention across multiple, optimally selected targets, using combinations of compounds at safe or submaximal doses, can achieve therapeutic effects while reducing toxicity and limiting mutational escape. A survey of known antimicrobials indicates that a small number of recurrent protein-level mechanisms account for most disruptions of microbial survival. We introduce metrics to detect these mechanisms across a pathogen proteome and describe a streamlined, modular workflow for target identification and prioritization that is optimized for ease of deployment and naturally interfaces with downstream applications such as molecular screening and

Identifiers

PMID42244761
PMCPMC13232245

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.